Related Experiment Video
Updated: Jun 3, 2026

Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension
Published on: November 15, 2024
Viral cirrhosis: an overview of haemostatic alterations and clinical consequences
Francesca Romana Ponziani1, Valerio De Stefano, Antonio Gasbarrini
1Department of Internal Medicine and Gastroentrology, Catholic University - Rome.
Insights
Viral hepatitis causes cirrhosis, leading to complex hemostatic (blood clotting) imbalances. This review examines altered blood clotting, bleeding, and thrombosis in cirrhosis patients, highlighting diagnostic challenges.
Area of Science:
- Hepatology
- Hematology
- Internal Medicine
Background:
- Viral hepatitis is a leading cause of cirrhosis and liver cancer globally.
- Cirrhosis leads to liver dysfunction and portal hypertension, presenting life-threatening complications.
- Altered hemostatic balance in cirrhosis complicates patient management, risking both bleeding and thrombosis.
Purpose of the Study:
- To review the principal aspects of procoagulant, anticoagulant, and fibrinolytic capacity in cirrhotic patients.
- To analyze the complex pathophysiological mechanisms of bleeding and thrombosis in cirrhosis.
- To discuss the limitations of current laboratory investigations in assessing hemostasis in cirrhosis.
Main Methods:
- Literature review of studies on hemostasis in liver cirrhosis.
- Analysis of procoagulant, anticoagulant, and fibrinolytic systems in cirrhotic patients.
- Discussion of pathophysiological mechanisms and clinical implications.
Main Results:
- Hemostatic balance in cirrhotic patients is variably altered, not solely predisposing to bleeding.
- Both bleeding manifestations and thrombosis can occur due to complex interactions of factors.
- Current laboratory tests offer only a partial view of the in vivo hemostatic condition.
Conclusions:
- Cirrhosis significantly impacts the entire hemostatic system, including clotting and anticoagulation.
- Bleeding and thrombosis in cirrhosis result from intricate interactions, not just advanced liver disease.
- Improved diagnostic tools are needed for a global overview of hemostasis in cirrhotic patients.
Abstract:
Viral hepatitis is a major health problem worldwide, the principal cause of cirrhosis and hepatocarcinoma. Once cirrhosis occurs, the consequences of liver dysfunction and portal hypertension become evident and, sometimes, life threatening for patients. Among the various complications of liver cirrhosis, the alteration of haemostatic balance is often a hard challenge for the clinician, since it is capable to predispose both to bleeding or thrombosis. In this review, we analyze the principal aspects of procoagulant, anticoagulant and fibrinolytic capacity of cirrhotic patients, which appears to be variably altered in all these aspects, not only in the direction of a tendency to bleeding. Laboratory investigations, at present, may provide only a partial representation of this condition, because of the impossibility to obtain a test capable to furnish a global overview of the haemostatic system and to reproduce in vivo conditions. Furthermore, we describe the pathophysiological mechanisms underlying bleeding manifestations and thrombosis development in cirrhotic patients, which should be considered not only as obvious consequences of the advanced liver disease but, rather, as the result of a complex interaction between inherited and acquired factors.
Related Concept Videos
Cirrhosis I: Introduction
Cirrhosis II: Pathophysiology
Viral Hepatitis I: Introduction
Esophageal Varices-I: Introduction
Hepatitis
Portal Hypertension

